Cargando…
In-Line Monitoring of Downstream Purification Processes for VSV Based SARS-CoV-2 Vaccine Using a Novel Technique
The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases the need for a rapid development of efficient vaccines. Among other vaccines in clinical trials, a recombinant VSV-∆G-spike vaccine was developed by the Israel Institute for Biological Research (II...
Autores principales: | Makovitzki, Arik, Jayson, Avital, Oren, Ziv, Lerer, Elad, Kafri, Yaron, Dor, Eyal, Cherry, Lilach, Tzadok, Hanan, Levin, Lilach, Hazan, Ophir, Simon, Irit, Tal, Arnon, Girshengorn, Meni, Rosen, Osnat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245488/ https://www.ncbi.nlm.nih.gov/pubmed/35822799 http://dx.doi.org/10.3390/biotech10040025 |
Ejemplares similares
-
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate
por: Makovitzki, Arik, et al.
Publicado: (2021) -
Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography
por: Lerer, Elad, et al.
Publicado: (2021) -
Optimization of VSV‐ΔG‐spike production process with the Ambr15 system for a SARS‐COV‐2 vaccine
por: Rosen, Osnat, et al.
Publicado: (2022) -
Application of Ambr15 system for simulation of entire SARS‐CoV‐2 vaccine production process involving macrocarriers
por: Jayson, Avital, et al.
Publicado: (2022) -
SARS-CoV-2 spike antigen quantification by targeted mass spectrometry of a virus-based vaccine
por: Rosen, Osnat, et al.
Publicado: (2022)